Hepatocellular Carcinoma: How the Gut Microbiota Contributes to Pathogenesis, Diagnosis, and Therapy

作者：Wenyu Luo, Shiqi Guo, Yang Zhou, Jingwen Zhao, Mengyao Wang, Li-Xuan Sang, Bing Chang, Bingyuan Wang · 发表于：Frontiers in Microbiology · 年份：2022 · DOI：10.3389/fmicb.2022.873160 · 被引用次数：54 · 研究领域：Gut microbiota and health、Pancreatic and Hepatic Oncology Research、Liver Disease Diagnosis and Treatment

The gut microbiota is gaining increasing attention, and the concept of the "gut-liver axis" is gradually being recognized. Leaky gut resulting from injury and/or inflammation can cause the translocation of flora to the liver. Microbiota-associated metabolites and components mediate the activation of a series of signalling pathways, thereby playing an important role in the development of hepatocellular carcinoma (HCC). For this reason, targeting the gut microbiota in the diagnosis, prevention, and treatment of HCC holds great promise. In this review, we summarize the gut microbiota and the mechanisms by which it mediates HCC development, and the characteristic alterations in the gut microbiota during HCC pathogenesis. Furthermore, we propose several strategies to target the gut microbiota for the prevention and treatment of HCC, including antibiotics, probiotics, faecal microbiota transplantation, and immunotherapy.